I-FABP is decreased in COVID-19 patients, independently of the prognosis.

I-FABP is decreased in COVID-19 patients, independently of the prognosis.

<h4>Background</h4>Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) is frequently associated with gastrointestinal manifestations. Herein we evaluated the interest in measuring the intestinal fatty acid-binding protein (I-FABP), a biomarker of intestinal inj...

Full description

Bibliographic Details
Main Authors: Kevin Guedj, Mathieu Uzzan, Damien Soudan, Catherine Trichet, Antonino Nicoletti, Emmanuel Weiss, Hana Manceau, Alexandre Nuzzo, Olivier Corcos, Xavier Treton, Katell Peoc'h
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0249799

Internet

https://doi.org/10.1371/journal.pone.0249799

Similar Items